Embed Size (px)
Citation preview
Precision medicine is redefining healthcare, driving a shift from the traditional “one size fits all” approach to a patient-centric care model that delivers the right treatment, at the right time, to the right patient.
Because we’re more than a lab, Quest Diagnostics shares your commitment to deliver the innovations and solutions in precision medicine that inspire better health.
Quest Advanced Precision Medicine & Pharma ServicesBringing precision medicine to life
Collaborate with one of the world’s leading providers of diagnostic testing, information, and services
The unique scale of our testing network, physician and hospital relationships, robust data, and medical and technical expertise offers pharmaceutical organizations an unparalleled opportunity to target new therapies to the right patient population, providing new hope to patients and their families.
Quest Advanced Precision Medicine & Pharma Services supports:
• Assay development, validation, and scale-up
• Commercial diagnostic testing services and market analytics capabilities
• Direct physician access to 1/3 of the US adult population each year
• End-to-end services from pre-clinical to regulatory approval and global commercialization
• Through our integrated solutions with Q2 Solutions®, we offer clinical trial wrap-around services, including central lab
• Pre-launch medical communications and proficiency training
Advanced diagnostics
A broad test menu of 3,500 tests, including companion diagnostic (CDx), complementary, and pharmacogenomic diagnostic tests that deliver insights across a variety of health conditions, from the routine to the complex
State-of-the-art technology
Next-Gen Sequencing (NGS) panels and multiplexed immunohistochemistry (mIHC) aid in the prediction, diagnosis, and treatment of disease and advancing precision medicine
Extensive service area
More than 2,200 Patient Service Centers across the US, service to 50% of US hospitals, and numerous esoteric laboratories throughout the world ensure easy accessibility to advanced testing
Actionable insights
More than 40 billion de-identified patient data points collected during the last decade empower patients and physicians to make more informed decisions that can lead to better patient care
End-to-end offering capability
Quest Diagnostics combines expertise with IQVIATM and our joint venture, Q2 Solutions, to offer an optimal partnership from preclinical support through global commercialization
Image content used for illustrative purposes only. Person depicted in the content is a model.
QuestDiagnostics.comQuest, Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks–® and TM–are the property of their respective owners. © 2019 Quest Diagnostics Incorporated. All rights reserved. SB8047 1/2019
Take advantage of our strategic, expert perspectiveThought leadership Our core competencies include technical, medical, and scientific knowledge across medical subspecialty and technology areas.
Extensive clinical support On-staff oncology experts dedicated to helping advance precision medicine. We also have more than 650 MDs and PhDs, and 35 genetic counselors to support test selection, consultation, and results interpretation.
Seasoned, expert analysis Data scientists and statisticians with decades of experience collecting, structuring, analyzing, and interpreting data.
Established relationships A strong history of collaboration with IVD kit manufacturers, leading academic institutions, such as UCSF, and industry leaders, including Memorial Sloan Kettering Cancer Center and IBM Watson to advance precision medicine.
We can collaborate with you to create a comprehensive solution—from idea to
launch of a companion diagnostic, or a targeted therapy test to target your drug to
the right patient population. Learn more about how you can take advantage of our
experience and leadership in precision medicine.
Contact us at [email protected]
Precision Medicine & Pharma ServicesThe right test, right patient, and right time—with the right lab partner
End-to-end services
Test development, FDA approval,
commercialization
Targeted therapytest development
Commercial testing
Clinical trialwrap-around services
Pre-launch medical communications
End-to-endservices
Commercializationof CDx test
REMS programs
Assay development,validation, and scale-up
Data analyticssupport for targeted
therapy
Custom testing services
Day 1 ready lab for new CDx test
launches
